| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Oct 9, 2026 | Founder Factory to showcase 19 university innovations ready for commercialization | Research developed at southeastern Wisconsin institutions could become the foundation for new startup companies.
Founder Factory will host Idea to Enterprise Pitch Night: University Innovations Ready for Launch on Wednesday, Oct. 14, from 5... |
| Oct 1, 2026 | Insurance coverage lags as cancer science, treatment move forward | Getting your Trinity Audio player ready...
By Arthur Allen, KFF Health News
Eighteen months after his initial diagnosis, chemotherapy hadn’t slowed 21-year-old Mason Henderson’s rare brain tumor, which had spread to his spinal fluid. So he ... |
| Jun 12, 2026 | Hansa Biopharma invite to Capital Markets Day 2026 in New York | Hansa Biopharma invite to Capital Markets Day 2026 in New York
Fri, Jun 12, 2026 07:00 CET Report this content
Lund, Sweden, June 12, 2026. Hansa Biopharma AB, “Hansa” (Nasdaq Stockholm: HNSA), is pleased to welcome investors and analysts t... |
| Jun 11, 2026 | BioForward event highlights emerging medical innovations at MCW | Researchers, physicians and the startup ecosystem gathered at the Medical College of Wisconsin‘s Center for Cancer Discovery on June 9 for “Behind Biohealth Breakthroughs: Southeast Wisconsin,” an event hosted by BioForward and MCW.
The pro... |
| May 28, 2026 | Founder Factory puts spotlight on innovations at ‘Ideas to Enterprise Pitch Night’ | Founder Factory hosted “Idea to Enterprise Pitch Night: University Innovations Ready for Launch” Thursday evening at the UWM Lubar Entrepreneurship Center.
The event showcased technologies developed at Marquette University, University of Wi... |
| Mar 30, 2026 | One man, his dog, and ChatGPT: Australia's AI vaccine saga | HONG KONG: Desperate to help his sick dog, one Australian man went down the ultimate ChatGPT research hole, using artificial intelligence to design a personalised experimental treatment and finding top scientists to administer it.
Paul Cony... |
| Feb 4, 2026 | Do you need to control your cortisol? Probably not, doctors say | Getting your Trinity Audio player ready...
By DEVI SHASTRI
Cortisol, what is known as the stress hormone, is the talk of the internet. Related Articles
Experimental cholesterol-lowering pill may offer new option for millions
Study ties part... |
| Nov 30, 2025 | Tundra Targeted Therapeutics prepares for human cancer trial | Milwaukee-based Tundra Targeted Therapeutics is advancing a homegrown cancer therapy toward Phase 1 clinical testing, marking a rare moment when a drug developed at a local research institution prepares to begin human trials in the same com... |
| Nov 12, 2025 | Upcoming KOL Call today: Insights on clinical practice and imlifidase Phase 3 Results | Upcoming KOL Call today: Insights on clinical practice and imlifidase Phase 3 Results
Wed, Nov 12, 2025 08:00 CET Report this content
Lund, Sweden, 12 November 2025. Hansa Biopharma AB, “Hansa” (Nasdaq Stockholm: HNSA) today will host a vir... |
| Oct 29, 2025 | Hansa hosts call with distinguished transplant surgeons: Insights on clinical practice and imlifidase Phase 3 Results | Hansa hosts call with distinguished transplant surgeons: Insights on clinical practice and imlifidase Phase 3 Results
Wed, Oct 29, 2025 18:00 CET Report this content
Lund, Sweden, 29 October 2025. Hansa Biopharma AB, “Hansa” (Nasdaq Stockho... |
| Oct 23, 2025 | APHON Announces 2025-2026 Board of Directors and Officers | The Association of Pediatric Hematology/Oncology Nurses (APHON) proudly announces the installation of its 2025–2026 officers and directors during the Annual Business Meeting held at the 49th Annual Conference and Exhibit in Providence, Rhod... |
| Jun 14, 2025 | Ryght AI: Revolutionizing Clinical Trials with Generative AI | In the world of clinical research, time is of the essence. Trials can take years, and every delay can mean lost lives. Enter Ryght AI, a Laguna Beach-based startup that is shaking up the industry with its innovative approach. The company re... |
| Jun 12, 2025 | Ryght AI Raises $3M in Seed Funding | Ryght AI, a Laguna Beach, CA based provider of real-time generative AI solutions for the clinical research industry, raised $3m in seed funding.
The round was led by Foothill Ventures with participation from existing investors AIX Ventures,... |
| Feb 20, 2025 | Gradientech: Year-end report 2024 | Gradientech: Year-end report 2024
Thu, Feb 20, 2025 08:00 CET Report this content
Gradientech AB (publ) year-end report for 2024 is now available on the company's website www.gradientech.se. Fourth quarter 2024 Net sales amounted to SE... |
| Feb 10, 2025 | Sanacor at the forefront of cardiometabolic innovation | Sanacor is on a mission to reverse diabetic cardiovascular disease, tackling a condition that is one of the leading causes of death for people with diabetes—yet has no effective treatments. With roots in more than two decades of research, t... |
| Jan 13, 2025 | Amruth Group positioned for growth in 2025 | Milwaukee-based Amruth Group, a startup making waves in the skincare industry, is gearing up for an exciting 2025. Building on the success of its anti-aging facial cream, the company is planning to expand its product line, explore new paten... |
| Nov 26, 2024 | Cilia Proteins: The New Frontier in Vascular Health Monitoring | In the intricate world of human biology, cilia are often overlooked. These tiny, hair-like structures are more than mere cellular decorations. They play a pivotal role in sensing blood flow and maintaining vascular health. Recent advancemen... |
| Nov 25, 2024 | Cilia Proteins as Biomarkers of Vascular Health, Upcoming Webinar Hosted by Xtalks | www.genscript.com
In this free webinar, learn about the latest developments related to the biomarker potential of cilia and their potential clinical applications. Attendees will learn about the role of endothelial cilia as blood flow sensor... |
| Oct 16, 2024 | Bright Minds Biosciences Stock Surges Almost 1,500% Bright Minds Biosciences (NASDAQ: DRUG) soared 1,445% in a single day, trading over 100 million shares without any news. |
Bright Minds Biosciences (NASDAQ: DRUG), a little-known biotech company, became the talk of the market yesterday after its stock skyrocketed by 1,445% in a single trading session. Typically trading under 1 million shares daily, the stock s... |
| Sep 20, 2024 | Disparities Narrowing Among Patients Undergoing Blood Stem Cell Transplant, Roswell Park Study Reveals | Roswell Park’s Theresa Hahn, PhD, led a new analysis that looked at trends in bone marrow transplant among patients of different ages, races and ethnicities.
Historically, some patients with blood cancers have been less likely than others t... |
| Sep 19, 2024 | A New Dawn in Kidney Cancer Treatment: Roswell Park's Breakthrough Regimen | In the realm of cancer treatment, hope often flickers like a candle in the dark. But recent findings from Roswell Park Comprehensive Cancer Center have ignited a brighter flame for patients battling metastatic kidney cancer. At the European... |
| Sep 15, 2024 | Roswell Park-Designed Treatment Regimen Doubles Progression-Free Survival in Metastatic Kidney Cancer | Roswell Park's Saby George, MD, presented study findings highlighting a treatment combination shown to extend survival in patients with advanced kidney cancer.
During the European Society for Medical Oncology (ESMO) Congress, Saby Geor... |
| Aug 12, 2024 | Nathan A Ledeboer joins the Scientific Advisory Board at Gradientech | Nathan A Ledeboer joins the Scientific Advisory Board at Gradientech
Mon, Aug 12, 2024 09:00 CET Report this content
The diagnostics company Gradientech today announces that Dr Nathan A. Ledeboer, specialist within the Froedtert & Medic... |
| Aug 2, 2024 | New Book Release - Love Letters to Patients: Restoring Trust While Navigating The U.S. Healthcare System | Sand & Shores
Dr. Ruby J. Long strives to improve the health outcomes of individual patients and marginalized groups with her emergency room experience.
This groundbreaking book is an essential tool for anyone in healthcare, emphasizing... |
| Jul 18, 2024 | NEJM publishes ALTUVOCT® phase 3 XTEND-Kids results highlighting treatment potential for children with severe haemophilia A | NEJM publishes ALTUVOCT® phase 3 XTEND-Kids results highlighting treatment potential for children with severe haemophilia A
Thu, Jul 18, 2024 08:00 CET Report this content XTEND-Kids is the first assessment of once-weekly ALTUVOCT® prophyla... |
| Jul 2, 2024 | Association for Diagnostics & Laboratory Medicine (formerly AACC) elects new leaders to serve terms starting in August 2024 | WASHINGTON, July 2, 2024 /PRNewswire/ -- The Association for Diagnostics & Laboratory Medicine (ADLM, formerly AACC) is pleased to announce that Paul Jannetto, PhD, DABCC, FADLM, MT(ASCP), has been elected to serve on the ADLM board of ... |
| Jun 28, 2024 | Winners of 2024 Wisconsin ORBIE Awards Announced By WisconsinCIO | Executives from State of Wisconsin, Schreiber Foods, Sub-Zero Group, Inc., Medical College of Wisconsin, Dairyland Power Cooperative, Hammel, Green & Abrahamson, Inc. & Green Bay Area Public Schools recognized for their Achievements... |
| May 10, 2024 | Triomics Revolutionizes Cancer Care with GenAI | Triomics, a trailblazing company in the realm of cancer care, has recently secured a whopping $15 million in funding from big players in Silicon Valley like Lightspeed, Nexus Venture Partners, General Catalyst, and Y Combinator. Founded by ... |
| May 10, 2024 | Triomics Secures $15M to Automate Oncology Workflows with GenAI | Triomics co-founders: Sarim Khan and Hrituraj Singh
What You Should Know:
– Triomics, a company leveraging generative AI to revolutionize cancer care, today announced securing $15 million in funding led by prominent Silicon Valley firms lik... |
| May 6, 2024 | Dr. Ahmed Z. Obeidat Named Finalist for the 2024 "CMSC Neuroinnovator of the Year" | Dr. Ahmed Z. Obeidat's MS Research Finalist for 2024 CMSC Neuroinnovator Award
Cytokind Sponsored Trial Design Treats Greatest Unmet Need in MS
INTERVALE, N.H., May 6, 2024 /PRNewswire-PRWeb/ -- Cytokind, Inc. is proud to announce that... |
| Mar 10, 2024 | MoonLake announces significant improvements with Nanobody® sonelokimab over 24 weeks in active psoriatic arthritis (PsA) and other important updates at its R&D Day | MoonLake announces significant improvements with Nanobody® sonelokimab over 24 weeks in active psoriatic arthritis (PsA) and other important updates at its R&D Day Positive 24-week data from the ARGO trial of sonelokimab in PsA: Signifi... |
| Feb 29, 2024 | Wisconsin's Drive for $75M Towards Personalized Medicine Innovation | Phase 2 EDA Tech Hub Funding Application Fueled by Collaboration
Madison, Wisconsin, Feb. 29, 2024 (GLOBE NEWSWIRE) -- Following Wisconsin’s designation as a Regional Technology and Innovations Hub (Tech Hub) from the Economic Development A... |
| Oct 9, 2023 | JoyStik and Sanacor win Healthcare Innovation Pitch Event | The Healthcare Innovation Pitch Event was held on Wednesday, October 4 at Wantable Café. Sponsored by Bridges to Cures, CTSI of Southeast Wisconsin, CU Ventures, and Accelerating Medical Product Development (AMPD) the event was a part of WI... |
| Oct 4, 2023 | Diverge TSL: Healthcare Startup Success | There is a concentrated effort in the city to expand and develop the healthcare startup ecosystem. Programs like AMPDNR, Bridge to Cures, and the Medical College of Wisconsin’s Therapeutic Accelerator Program all serve to foster healthcare ... |
| Nov 3, 2022 | Local HealthTech startups shine | Will the next big thing in healthcare be created in Milwaukee?
Local innovators are counting on it.
Area academic research institutions have united to advance the development of drugs, devices, HealthTech software and new clinical deliver... |
| Feb 15, 2022 | Local Non-Profit Partners with Rock Legend to Fight Rare Disease | “Inclusion Body Myositis and other rare diseases affect more than 350 million people globally, yet we still know so little about many of these diseases,” said Grammy Award winning artist Peter Frampton.
CHICAGO (PRWEB) February 15, 2022
Har... |
| Sep 21, 2021 | BetterLife Pharma : On September 16, 2021, the Company issued 2,500 common shares to a third party pursuant to vesting of restricted stock units (Form 6-K) | On September 16, 2021, the Company issued 2,500 common shares to a third party pursuant to vesting of restricted stock units.
Full Description of Material Change
Refer to Item 4 and the news release in Schedule "A".
Reliance on su... |
| Sep 9, 2021 | BetterLife Enters Research Agreement with Medical College Wisconsin for TD-0148A Neurological Receptor Studies | VANCOUVER, British Columbia, Sept. 09, 2021 (GLOBE NEWSWIRE) -- BetterLife Pharma Inc. (“BetterLife” or the “Company”) (CSE: BETR / OTCQB: BETRF / FRA: NPAU), an emerging biotechnology company primarily focused on developing compounds to tr... |
| Sep 17, 2020 | With Covid-19, healthcare in-house counsel face their greatest test yet | Werner Boel, a senior partner with executive recruiter Witt Kieffer in its Atlanta office, said even before the public health crisis the role of the in-house counsel for hospitals and health systems was evolving.
“They need to be a strategi... |
| Sep 26, 2018 | Somna Rebrands Acid Reflux Band in Bid to Reach More Patients | Share Share on Facebook Share on Twitter LinkedIn Email Reprints
There’s a long list of products named after their inventors: everything from the diesel engine to Jacuzzi tubs to the leotard.
For years, the list had also included Reza Band,... |
| Jan 3, 2017 | When does refusing treatment cross line to euthanasia? | “I was always interested in organ donation and had checked the box on my license,” Adox said last spring at his home in South Orange, New Jersey, through a machine that spoke for him. He laboriously spelled out these words, letter by letter... |
| Apr 6, 2016 | Latest gBETA Class Unveiled, Suggests Ties With WARF Are Solidifying | Share Share on Facebook Share on Twitter LinkedIn Email Reprints
In November, the startup accelerator Gener8tor announced a partnership with the Wisconsin Alumni Research Foundation, which manages patents and licensing of intellectual prope... |
| Mar 19, 2014 | UW-Milwaukee Students to Design Healthcare Apps for MCW | Share Share on Facebook Share on Twitter LinkedIn Email Reprints
A searchable database of open clinical trials, a mobile calculator and calendar for helping patients on steroids decrease their dosage over time, and a mobile tracker for bloo... |
| Jul 21, 2010 | Early stage drug developer Cytometix raises $1.9M in equity | Cytometix has collaborated with the Medical College of Wisconsin in developing the drug. David Harder, Cytometix’s chief scientific consultant, is the former director of the Medical College of Wisconsin’s Cardiovascular Center.
The pain dru... |
| With Covid-19, healthcare in-house counsel face their greatest test yet | At any given time, healthcare in-house counsel have a lot on their plates. This includes, but is not limited to, negotiating contracts as part of the broader consolidation trend in healthcare, adapting to regulatory changes from the FDA and... |
| Early stage drug developer Cytometix raises $1.9M in equity | Cytometix Inc. has raised $1.9 million in equity to further development of a drug that treats pain, according to a Securities and Exchange Commission filing.
The company plans to use the funding to take the drug to the point at which it can... |
| When does refusing treatment cross line to euthanasia? | At 44 years old, Dave Adox was facing the end of his two-year battle with ALS, also known as Lou Gehrig’s disease. He needed a ventilator to breathe and couldn’t move any part of his body, except his eyes. Once he started to struggle with h... |
